BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19078928)

  • 1. Current treatment of metastatic endometrial cancer.
    Temkin SM; Fleming G
    Cancer Control; 2009 Jan; 16(1):38-45. PubMed ID: 19078928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic therapy for advanced endometrial cancer].
    Pautier P; Pommeret F
    Bull Cancer; 2017 Dec; 104(12):1046-1053. PubMed ID: 29157555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the chemotherapeutic management of endometrial cancer.
    Bregar A; Robison K; Dizon DS
    Clin Adv Hematol Oncol; 2014 Oct; 12(10):659-65. PubMed ID: 25658891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management Strategies for Recurrent Endometrial Cancer.
    Connor EV; Rose PG
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):873-885. PubMed ID: 29972650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.
    Papa A; Zaccarelli E; Caruso D; Vici P; Benedetti Panici P; Tomao F
    Expert Opin Investig Drugs; 2016; 25(1):31-49. PubMed ID: 26560489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers?
    Steed HL; Chu QS
    Expert Opin Investig Drugs; 2011 May; 20(5):681-90. PubMed ID: 21413907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs in endometrial cancers.
    Altundag O; Dursun P; Ayhan A
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):557-68. PubMed ID: 20828226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The validity of chemotherapy in the treatment of endometrial cancer].
    Fehr MK; Streich MS
    Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):34-8. PubMed ID: 16452818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's new in systemic therapy for endometrial cancer.
    Kieser K; Oza AM
    Curr Opin Oncol; 2005 Sep; 17(5):500-4. PubMed ID: 16093803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the current pharmacotherapy for endometrial cancer.
    de Haydu C; Black JD; Schwab CL; English DP; Santin AD
    Expert Opin Pharmacother; 2016; 17(4):489-99. PubMed ID: 26629895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
    Husseinzadeh N; Husseinzadeh HD
    Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic therapy in metastatic or recurrent endometrial cancer.
    Pectasides D; Pectasides E; Economopoulos T
    Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic therapy for advanced endometrial cancer].
    Tazi Y; Pautier P; Lhommé C
    Bull Cancer; 2012 Jan; 99(1):93-7. PubMed ID: 22236886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of endometrial cancer.
    Fowler W; Mutch D
    Womens Health (Lond); 2008 Sep; 4(5):479-89. PubMed ID: 19072487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies.
    Bansal N; Yendluri V; Wenham RM
    Cancer Control; 2009 Jan; 16(1):8-13. PubMed ID: 19078924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial cancer-targeted therapies myth or reality? Review of current targeted treatments.
    Lheureux S; Oza AM
    Eur J Cancer; 2016 May; 59():99-108. PubMed ID: 27017291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial cancer: Molecular markers and management of advanced stage disease.
    Arend RC; Jones BA; Martinez A; Goodfellow P
    Gynecol Oncol; 2018 Sep; 150(3):569-580. PubMed ID: 29843906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy in metastatic or recurrent endometrial carcinoma].
    Deppe G; Baumann P; Munkarah A
    Zentralbl Gynakol; 2000; 122(7):355-60. PubMed ID: 10951705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic therapy for recurrent endometrial cancer: a review of North American trials.
    Dellinger TH; Monk BJ
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):905-16. PubMed ID: 19589030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting fibroblast growth factor pathways in endometrial cancer.
    Winterhoff B; Konecny GE
    Curr Probl Cancer; 2017; 41(1):37-47. PubMed ID: 28041631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.